CEVCellaVisionSE0000683484CEVICEVI
There is no discussion about the security yet. Share your thoughts now!
Financials
Market Cap
$652.74M5Y beta
1.11EPS (TTM)
$0.599Free Float
19.71MP/E ratio (TTM)
45.71Revenue (TTM)
$71.51MEBITDA (TTM)
$22.17MFree Cashflow (TTM)
$12.71MPricing
Analyst Ratings
The price target is $25.59 and the stock is covered by 3 analysts.
Buy
1
Hold
2
Sell
0
Information
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.